These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 24371562)

  • 1. IgM phosphorylcholine antibodies inhibit cell death and constitute a strong protection marker for atherosclerosis development, particularly in combination with other auto-antibodies against modified LDL.
    Fiskesund R; Su J; Bulatovic I; Vikström M; de Faire U; Frostegård J
    Results Immunol; 2012; 2():13-8. PubMed ID: 24371562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies against native and oxidized cardiolipin and phosphatidylserine and phosphorylcholine in atherosclerosis development.
    Frostegård AG; Su J; Hua X; Vikström M; de Faire U; Frostegård J
    PLoS One; 2014; 9(12):e111764. PubMed ID: 25473948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies of IgM subclass to phosphorylcholine and oxidized LDL are protective factors for atherosclerosis in patients with hypertension.
    Su J; Georgiades A; Wu R; Thulin T; de Faire U; Frostegård J
    Atherosclerosis; 2006 Sep; 188(1):160-6. PubMed ID: 16307748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgM antibodies against malondialdehyde and phosphorylcholine are together strong protection markers for atherosclerosis in systemic lupus erythematosus: Regulation and underlying mechanisms.
    Rahman M; Sing S; Golabkesh Z; Fiskesund R; Gustafsson T; Jogestrand T; Frostegård AG; Hafström I; Liu A; Frostegård J
    Clin Immunol; 2016 May; 166-167():27-37. PubMed ID: 27102765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low levels of IgM antibodies against phosphorylcholine are associated with fast carotid intima media thickness progression and cardiovascular risk in men.
    Gigante B; Leander K; Vikström M; Baldassarre D; Veglia F; Strawbridge RJ; McLeod O; Gertow K; Sennblad B; Shah S; Zabaneh D; Humphries SE; Kauhanen J; Rauramaa R; Smit AJ; Mannarino E; Giral P; Tremoli E; Hamsten A; Frostegård J; de Faire U;
    Atherosclerosis; 2014 Oct; 236(2):394-9. PubMed ID: 25150937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased prevalence of vulnerable atherosclerotic plaques and low levels of natural IgM antibodies against phosphorylcholine in patients with systemic lupus erythematosus.
    Anania C; Gustafsson T; Hua X; Su J; Vikström M; de Faire U; Heimbürger M; Jogestrand T; Frostegård J
    Arthritis Res Ther; 2010; 12(6):R214. PubMed ID: 21092251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different subclasses and isotypes of antibodies against phosphorylcholine in haemodialysis patients: association with mortality.
    Samal SK; Qureshi AR; Rahman M; Stenvinkel P; Frostegård J
    Clin Exp Immunol; 2020 Jul; 201(1):94-104. PubMed ID: 32297318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural antibodies against phosphorylcholine in cardiovascular disease.
    de Faire U; Frostegård J
    Ann N Y Acad Sci; 2009 Sep; 1173():292-300. PubMed ID: 19758165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgM anti-phosphorylcholine antibodies associate with senescent and IL-17+ T cells in SLE patients with a pro-inflammatory lipid profile.
    López P; Rodríguez-Carrio J; Martínez-Zapico A; Pérez-Álvarez ÁI; Benavente L; Caminal-Montero L; Suárez A
    Rheumatology (Oxford); 2020 Feb; 59(2):407-417. PubMed ID: 31302689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Higher levels of anti-phosphorylcholine autoantibodies in early rheumatoid arthritis indicate lower risk of incident cardiovascular events.
    Ajeganova S; Andersson MLE; Frostegård J; Hafström I
    Arthritis Res Ther; 2021 Jul; 23(1):201. PubMed ID: 34311770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential natural immunization against atherosclerosis in hibernating bears.
    Samal SK; Fröbert O; Kindberg J; Stenvinkel P; Frostegård J
    Sci Rep; 2021 Jun; 11(1):12120. PubMed ID: 34108551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Passive immunization with monoclonal IgM antibodies against phosphorylcholine reduces accelerated vein graft atherosclerosis in apolipoprotein E-null mice.
    Faria-Neto JR; Chyu KY; Li X; Dimayuga PC; Ferreira C; Yano J; Cercek B; Shah PK
    Atherosclerosis; 2006 Nov; 189(1):83-90. PubMed ID: 16386745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgM antibodies against phosphorylcholine promote polarization of T regulatory cells from patients with atherosclerotic plaques, systemic lupus erythematosus and healthy donors.
    Sun J; Lundström SL; Zhang B; Zubarev RA; Steuer J; Gillgren P; Rahman M; Ajeganova S; Liu A; Frostegård J
    Atherosclerosis; 2018 Jan; 268():36-48. PubMed ID: 29175653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylcholine antibodies are diminished in ANCA-associated vasculitis.
    Wilde B; Slot M; van Paassen P; Theunissen R; Kemna M; Witzke O; Cohen Tervaert JW
    Eur J Clin Invest; 2015 Jul; 45(7):686-91. PubMed ID: 25940757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low levels of IgM antibodies to phosphorylcholine predict cardiovascular disease in 60-year old men: effects on uptake of oxidized LDL in macrophages as a potential mechanism.
    de Faire U; Su J; Hua X; Frostegård A; Halldin M; Hellenius ML; Wikström M; Dahlbom I; Grönlund H; Frostegård J
    J Autoimmun; 2010 Mar; 34(2):73-9. PubMed ID: 19726160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies against phosphorylcholine and protection against atherosclerosis, cardiovascular disease and chronic inflammation.
    Frostegård J
    Expert Rev Clin Immunol; 2022 May; 18(5):525-532. PubMed ID: 35471137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal levels of apolipoproteins and antibodies against phosphorylcholine are independently associated with carotid artery atherosclerosis 5 years after rheumatoid arthritis onset--a prospective cohort study.
    Ajeganova S; Ehrnfelt C; Alizadeh R; Rohani M; Jogestrand T; Hafström I; Frostegård J
    Rheumatology (Oxford); 2011 Oct; 50(10):1785-93. PubMed ID: 21743088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies Against Phosphorylcholine Among 60-Year-Olds: Clinical Role and Simulated Interactions.
    Samal SK; Panda PK; Vikström M; Leander K; de Faire U; Ahuja R; Frostegård J
    Front Cardiovasc Med; 2022; 9():809007. PubMed ID: 35479288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Auto-antibodies do not influence development of atherosclerotic plaques in rheumatoid arthritis.
    Pereira I; Laurindo I; Burlingame R; Anjos L; Viana V; Leon E; Vendramini M; Borba E
    Joint Bone Spine; 2008 Jul; 75(4):416-21. PubMed ID: 18457983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgM antibodies against malondialdehyde and phosphorylcholine in different systemic rheumatic diseases.
    Thiagarajan D; Oparina N; Lundström S; Zubarev R; Sun J; ; Alarcon-Riquelme M; Frostegård J
    Sci Rep; 2020 Jul; 10(1):11010. PubMed ID: 32620913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.